Pink Sheet Podcast: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms

Pink Sheet reporter and editors discuss former Surgeon General Jerome Adams’ views on how the FDA can better ensure clinical trial diversity, questions about approving a new drug that would be used with a standard of care regimen that is off-label, and the agency beginning to schedule fully in-person advisory committee meetings.

Pink Sheet podcast
Will advisory committee meetings change upon their return to fully in-person sessions? • Source: Citeline/Shutterstock

More from Diversity & Inclusion

More from Clinical Trials